Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Gabriel N. Hortobágyi
Sign up to set email alerts
2,187
Publications
95,170
Citation Statements Received
25,278
Citation Statements Given
How they've been cited
142,722
3,953
90,591
626
How they cite others
46,911
1,081
24,049
148
Affiliations
The University of Texas MD Anderson Cancer Center
,
Anderson Hospital
Publications
Order By: Most citations
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
Baselga
1
,
Campone
2
,
Piccart
3
et al.
2012
N Engl J Med
Abstract
Show
2,922
59
2,265
7
Get access via publisher
Add to collection
Cite
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
Liedtke
1
,
Mazouni
2
,
Hess
3
et al.
2008
JCO
Abstract
Show
3,003
101
2,172
21
Get access via publisher
Add to collection
Cite
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
Hortobágyi
1
,
Stemmer
2
,
Burris
3
et al.
2016
N Engl J Med
Abstract
Show
2,136
59
1,653
8
2
Get access via publisher
Add to collection
Cite
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Nagata
1
,
Lan
2
,
Zhou
3
et al.
2004
Cancer Cell
Abstract
Show
1,845
60
1,341
9
Get access via publisher
Add to collection
Cite
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
Symmans
1
,
Peintinger
2
,
Hatzis
3
et al.
2007
JCO
Abstract
Show
1,738
20
1,273
1
Get access via publisher
Add to collection
Cite
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
Rouzier
1
,
Perou
2
,
Symmans
3
et al.
2005
Abstract
Show
1,860
73
1,134
8
Get access via publisher
Add to collection
Cite
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Toy
1
,
Shen
2
,
Won
3
et al.
2013
Nat Genet
Abstract
Show
1,328
55
1,200
3
Get access via publisher
Add to collection
Cite
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
Li
1
,
Lim
2
,
Xia
3
et al.
2016
Nat Commun
Abstract
Show
1,196
44
1,111
7
Get access via publisher
Add to collection
Cite
1
2
3
4